Active G alpha (i)–i1/i2/i3 binds RGS proteins

Stable Identifier
R-HSA-8982019
Type
Reaction [binding]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

G Protein Coupled Receptors (GPCR) sense extracellular signals and activate different Guanine nucleotide binding proteins (G proteins). Upon activation, GPCRs can replace the GDP with GTP in the alpha subunit of G proteins. GTP binding modifies the conformation of G alpha proteins and activates them. The Regulator of G protein Signalling (RGS) proteins are GTPase Accelerating Proteins (GAPs) that can inhibit the G alpha subunit activity via their GAP activity. There are at least 25 different types of RGS proteins known. Several of these RGS proteins (1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 17, 18, 19, 20, 21) can bind and stabilize the transition state for GTP hydrolysis of Guanine nucleotide binding protein G(i) subunit alpha (GNAI). Subsequently, this leads to GTP hydrolysis and inactivation of GNAI and terminating downstream signalling (Neubig & Siderovski DP 2002, Kach et al. 2012). The primary function of GNAI is the inhibition of adenylate cyclase.

Literature References
PubMed ID Title Journal Year
18434541 Structural diversity in the RGS domain and its interaction with heterotrimeric G protein alpha-subunits

Soundararajan, M, Willard, FS, Kimple, AJ, Turnbull, AP, Ball, LJ, Schoch, GA, Gileadi, C, Fedorov, OY, Dowler, EF, Higman, VA, Hutsell, SQ, Sundström, M, Doyle, DA, Siderovski, DP

Proc. Natl. Acad. Sci. U.S.A. 2008
12120503 Regulators of G-protein signalling as new central nervous system drug targets

Neubig, RR, Siderovski, DP

Nat Rev Drug Discov 2002
Participants
Participant Of
Orthologous Events
Authored
Reviewed
Created